PATENT CLAIM ANALYSIS

Application Number: 16119862
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["435", "366000"]

Abstract:
The present invention provides methods to promote differentiation of pancreatic endoderm cells to pancreatic endocrine rich clusters and to enhance insulin expression in hormone-expressing cells.

Claim (Index 6):
The method of  claim 1 , wherein the expression of ghrelin is suppressed in the population of pancreatic endoderm cells treated with Activin A or Activin C as compared to the expression of ghrelin in a population of pancreatic endoderm cells non-treated with Activin A or Activin C.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 96.0
- Lexical Diversity: 1.18182
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15340418', '13911829', '13708369', '14706310', '13998883']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6400058601194176
- 35 USC 102 Novelty (BERT): 0.6019526654371377
- Combined Prediction Score: 0.6362005406511897
- Mean Citation Score: 552.465556
- Max Citation Score: 642.1935
- Similarity Product: 427.777508498311

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test